These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 25580161)

  • 1. Alpha-synuclein biology in Lewy body diseases.
    Kim WS; Kågedal K; Halliday GM
    Alzheimers Res Ther; 2014; 6(5):73. PubMed ID: 25580161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
    Peng C; Gathagan RJ; Lee VM
    Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons.
    Fouka M; Mavroeidi P; Tsaka G; Xilouri M
    Front Cell Dev Biol; 2020; 8():559791. PubMed ID: 33015057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.
    Sengupta U; Guerrero-Muñoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R
    Biol Psychiatry; 2015 Nov; 78(10):672-83. PubMed ID: 25676491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are synucleinopathies prion-like disorders?
    Angot E; Steiner JA; Hansen C; Li JY; Brundin P
    Lancet Neurol; 2010 Nov; 9(11):1128-38. PubMed ID: 20846907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurons and Glia Interplay in α-Synucleinopathies.
    Mavroeidi P; Xilouri M
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.
    Rey NL; George S; Brundin P
    Neuropathol Appl Neurobiol; 2016 Feb; 42(1):51-76. PubMed ID: 26666838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prion Properties of Alpha-Synuclein].
    Schwarzman AL; Senkevich KA; Emelyanov AK; Pchelina SN
    Mol Biol (Mosk); 2019; 53(3):380-387. PubMed ID: 31184602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
    Iwatsubo T
    J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
    Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
    Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies.
    Gámez-Valero A; Beyer K
    Genes (Basel); 2018 Jan; 9(2):. PubMed ID: 29370097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
    Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
    Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
    Uversky VN
    J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Modes of Intercellular α-Synuclein Transmission.
    Valdinocci D; Radford RA; Siow SM; Chung RS; Pountney DL
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.